Dr. Dima Abdul Jabbar

Dr. Dima Abdul Jabbar is a distinguished Consultant Medical Oncologist and Director of the Burjeel Breast Center at Burjeel Hospital, Abu Dhabi. With 21 years of clinical oncology practice, she is a leading authority in breast oncology and solid tumor pharmacotherapies in the UAE.

She completed her medical degree from Damascus University Faculty of Medicine in 2000, followed by internal medicine residency and hematology/oncology fellowship training in the United States at the University of Texas Medical Branch. She holds Diplomate Certification from the American Board of Internal Medicine (ABIM) in Medical Oncology.

Clinical Expertise & Key Focus Areas:

• Personalized systemic chemotherapy and targeted biological therapy for solid tumors
• Specialized multidisciplinary management of early-stage and metastatic breast cancer
• Novel immune checkpoint inhibitor therapy and customized oncology treatment pathways
• Hereditary cancer risk assessment, genetic counseling coordination, and cancer survivorship care

A member of the American Society of Clinical Oncology (ASCO), Dr. Abdul Jabbar fosters an empowering, patient-centric environment where cancer patients and their families receive holistic and cutting-edge cancer care.